Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31truetruetruetruetruefalse2024-04-01false00truefalse 02323287 2024-04-01 2025-03-31 02323287 2023-04-01 2024-03-31 02323287 2025-03-31 02323287 2024-03-31 02323287 2023-04-01 02323287 1 2024-04-01 2025-03-31 02323287 1 2023-04-01 2024-03-31 02323287 d:Director1 2024-04-01 2025-03-31 02323287 d:Director2 2024-04-01 2025-03-31 02323287 d:Director3 2024-04-01 2025-03-31 02323287 d:Director4 2024-04-01 2025-03-31 02323287 d:Director5 2024-04-01 2025-03-31 02323287 d:Director8 2024-04-01 2025-03-31 02323287 d:Director9 2024-04-01 2025-03-31 02323287 d:RegisteredOffice 2024-04-01 2025-03-31 02323287 d:Agent1 2024-04-01 2025-03-31 02323287 e:Buildings 2024-04-01 2025-03-31 02323287 e:Buildings e:LongLeaseholdAssets 2024-04-01 2025-03-31 02323287 e:Buildings e:LongLeaseholdAssets 2025-03-31 02323287 e:Buildings e:LongLeaseholdAssets 2024-03-31 02323287 e:PlantMachinery 2024-04-01 2025-03-31 02323287 e:PlantMachinery 2025-03-31 02323287 e:PlantMachinery 2024-03-31 02323287 e:PlantMachinery e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 02323287 e:MotorVehicles 2024-04-01 2025-03-31 02323287 e:MotorVehicles 2025-03-31 02323287 e:MotorVehicles 2024-03-31 02323287 e:MotorVehicles e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 02323287 e:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 02323287 e:OtherPropertyPlantEquipment 2025-03-31 02323287 e:OtherPropertyPlantEquipment 2024-03-31 02323287 e:OtherPropertyPlantEquipment e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 02323287 e:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 02323287 e:CurrentFinancialInstruments 2025-03-31 02323287 e:CurrentFinancialInstruments 2024-03-31 02323287 e:Non-currentFinancialInstruments 2025-03-31 02323287 e:Non-currentFinancialInstruments 2024-03-31 02323287 e:CurrentFinancialInstruments e:WithinOneYear 2025-03-31 02323287 e:CurrentFinancialInstruments e:WithinOneYear 2024-03-31 02323287 e:Non-currentFinancialInstruments e:AfterOneYear 2025-03-31 02323287 e:Non-currentFinancialInstruments e:AfterOneYear 2024-03-31 02323287 e:Non-currentFinancialInstruments e:BetweenOneTwoYears 2025-03-31 02323287 e:Non-currentFinancialInstruments e:BetweenOneTwoYears 2024-03-31 02323287 e:Non-currentFinancialInstruments e:BetweenTwoFiveYears 2025-03-31 02323287 e:Non-currentFinancialInstruments e:BetweenTwoFiveYears 2024-03-31 02323287 e:UKTax 2024-04-01 2025-03-31 02323287 e:UKTax 2023-04-01 2024-03-31 02323287 e:ShareCapital 2024-04-01 2025-03-31 02323287 e:ShareCapital 2025-03-31 02323287 e:ShareCapital 2023-04-01 2024-03-31 02323287 e:ShareCapital 2024-03-31 02323287 e:ShareCapital 2023-04-01 02323287 e:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 02323287 e:RetainedEarningsAccumulatedLosses 2025-03-31 02323287 e:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 02323287 e:RetainedEarningsAccumulatedLosses 2024-03-31 02323287 e:RetainedEarningsAccumulatedLosses 2023-04-01 02323287 e:AcceleratedTaxDepreciationDeferredTax 2025-03-31 02323287 e:AcceleratedTaxDepreciationDeferredTax 2024-03-31 02323287 e:TaxLossesCarry-forwardsDeferredTax 2025-03-31 02323287 e:TaxLossesCarry-forwardsDeferredTax 2024-03-31 02323287 e:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2024-04-01 2025-03-31 02323287 e:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2025-03-31 02323287 e:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2024-03-31 02323287 d:OrdinaryShareClass1 2024-04-01 2025-03-31 02323287 d:OrdinaryShareClass1 2025-03-31 02323287 d:OrdinaryShareClass1 2024-03-31 02323287 d:FRS102 2024-04-01 2025-03-31 02323287 d:Audited 2024-04-01 2025-03-31 02323287 d:FullAccounts 2024-04-01 2025-03-31 02323287 d:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 02323287 e:WithinOneYear 2025-03-31 02323287 e:WithinOneYear 2024-03-31 02323287 e:BetweenOneFiveYears 2025-03-31 02323287 e:BetweenOneFiveYears 2024-03-31 02323287 e:MoreThanFiveYears 2025-03-31 02323287 e:MoreThanFiveYears 2024-03-31 02323287 2 2024-04-01 2025-03-31 02323287 f:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 02323287









BIOGAS TECHNOLOGY LIMITED









DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

 
BIOGAS TECHNOLOGY LIMITED
 
 
COMPANY INFORMATION


Directors
I A Gadsby 
C J Hull 
T H Scott 
A P R Ward 
S L Watson 
P Noland 
N A D Brooks 




Registered number
02323287



Registered office
Edison House
Daniel Adamson Road

Salford

Manchester

M50 1DT




Independent auditor
Forvis Mazars LLP

Chartered Accountants and Statutory Auditor

1 St Peter's Square

Manchester

M2 3DE




Bankers
Barclays Bank plc

Leicester

Leicestershire

LE87 2BB




Solicitors
Stevens & Bolton LLP
Wey House

Farnham Road

Guildford

GU1 4YD





 
BIOGAS TECHNOLOGY LIMITED
 

CONTENTS



Page
Directors' Report
1 - 2
Independent Auditor's Report
3 - 5
Profit and Loss Account
6
Balance Sheet
7 - 8
Statement of Changes in Equity
9
Notes to the Financial Statements
10 - 23


 
BIOGAS TECHNOLOGY LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025

The directors present their report and the financial statements for the year ended 31 March 2025.

Principal activity

The principal activities of the Company are the provision of environmental services, including the design, manufacture, implementation and sale of engineering solutions on landfill gas sites, together with the development, construction and operation of electricity generation and storage facilities in the UK.

Results and dividends

The loss for the year, after taxation, amounted to £635,722 (2024 -  £664,274).

The directors do not recommend the payment of a dividend (2024: £Nil).

Directors

The directors who served during the year were:

I A Gadsby 
C J Hull 
T H Scott 
A P R Ward 
S L Watson 
P Noland 
N A D Brooks 


Directors' responsibilities statement

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the company's financial statements and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Page 1

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025

Principal risk management objectives and exposures

The directors periodically review and agree objectives for managing key risks. These risks and the way in which the Company seeks to manage them, are summarised below:

Liquidity risk and interest rate risk

The Company seeks to manage financial risk by ensuring sufficient liquidity is available to meet foreseeable needs and to invest cash assets safely and profitably.

Credit risk

The principal credit risk arises from the Company's trade debtors. Credit risk is minimised by obtaining credit reports for all prospective customers before contracts are signed.

Qualifying third party indemnity provisions

Ylem Group Limited (the 'Ultimate parent undertaking') has appropriate Directors' and Officers' insurance covering all Directors for all subsidiaries within the Group.

Going Concern

The financial statements have been prepared on the going concern basis for the reasons set out in note 2.3.

Disclosure of information to auditor

The directors confirm that:
 
so far as the directors are aware, there is no relevant audit information of which the Company's auditor is unaware, and

the directors have taken all the steps that they ought to have taken as directors in order to make themselves aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

Auditor

The auditor, Forvis Mazars LLPwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

Small companies note

In preparing this report, the directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.

This report was approved by the board on 25 November 2025 and signed on its behalf.
 





P Noland
Director

Page 2

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF BIOGAS TECHNOLOGY LIMITED
 

Opinion

We have audited the financial statements of Biogas Technology Limited (the ‘company’) for the year ended 31 March 2025 which comprise the Profit and loss account, the Balance sheet, the Statement of changes in equity  and notes to the financial statements, including a summary of significant accounting policies.

The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:
give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the “Auditor’s responsibilities for the audit of the financial statements” section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. 
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the Annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report.  Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.
Page 3

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF BIOGAS TECHNOLOGY LIMITED
 


Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:
the information given in the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the directors' report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors’ report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors’ remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit; or
the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies’ exemption in preparing the directors’ report and from the requirement to prepare a strategic report.

Responsibilities of Directors

As explained more fully in the directors’ responsibilities statement set out on page 1, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial statements. 

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. 

Based on our understanding of the company and its industry, we considered that non-compliance with the following laws and regulations might have a material effect on the financial statements: employment regulation, health and safety regulation and anti-money laundering regulation.
Page 4

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF BIOGAS TECHNOLOGY LIMITED
 


To help us identify instances of non-compliance with these laws and regulations, and in identifying and assessing the risks of material misstatement in respect to non-compliance, our procedures included, but were not limited to:
Inquiring of management and, where appropriate, those charged with governance, as to whether the company is in compliance with laws and regulations, and discussing their policies and procedures regarding compliance with laws and regulations;
Inspecting correspondence, if any, with relevant licensing or regulatory authorities;
Communicating identified laws and regulations to the engagement team and remaining alert to any indications of non-compliance throughout our audit; and
Considering the risk of acts by the company which were contrary to applicable laws and regulations, including fraud.  

We also considered those laws and regulations that have a direct effect on the preparation of the financial statements, such as tax legislation, and the Companies Act 2006. 

In addition, we evaluated the directors’ and management’s incentives and opportunities for fraudulent manipulation of the financial statements, including the risk of management override of controls, and determined that the principal risks related to posting manual journal entries to manipulate financial performance, management bias through judgements and assumptions in significant accounting estimates, revenue recognition (which we pinpointed to the cut off assertion), and significant one-off or unusual transactions. 

Our audit procedures in relation to fraud included but were not limited to:
Making enquiries of the directors and management on whether they had knowledge of any actual, suspected or alleged fraud;
Gaining an understanding of the internal controls established to mitigate risks related to fraud;
Discussing amongst the engagement team the risks of fraud; and
Addressing the risks of fraud through management override of controls by performing journal entry testing.

There are inherent limitations in the audit procedures described above and the primary responsibility for the prevention and detection of irregularities including fraud rests with management. As with any audit, there remained a risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal controls.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorresponsibilities. This description forms part of our auditor’s report.

Use of the audit report

This report is made solely to the company’s members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body for our audit work, for this report, or for the opinions we have formed.


 
Christopher Martin (Senior Statutory Auditor) 
for and on behalf of Forvis Mazars LLP
Chartered Accountants and Statutory Auditor 
1 St Peters Square
Manchester M2 3DE
25 November 2025
Page 5

 
BIOGAS TECHNOLOGY LIMITED
 
 
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2025

2025
2024
Note
£
£

  

Turnover
 4 
7,517,791
7,988,217

Cost of sales
  
(6,612,079)
(6,538,896)

Gross profit
  
905,712
1,449,321

Administrative expenses
  
(168,823)
(969,825)

Release of bad debt provision
  
-
419,480

Operating profit
 5 
736,889
898,976

Interest receivable and similar income
  
47,634
15,468

Interest payable and similar expenses
 8 
(984,865)
(1,844,043)

Loss before tax
  
(200,342)
(929,599)

Tax on loss
 9 
(435,380)
265,325

Loss for the financial year
  
(635,722)
(664,274)

The notes on pages 10 to 23 form part of these financial statements.

Page 6

 
BIOGAS TECHNOLOGY LIMITED
 

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 10 
14,698,029
15,471,327

  
14,698,029
15,471,327

Current assets
  

Stocks
 11 
155,742
-

Debtors: amounts falling due within one year
 12 
1,022,643
1,139,341

Cash at bank and in hand
 13 
2,323,405
2,152,042

  
3,501,790
3,291,383

Creditors: amounts falling due within one year
 14 
(1,537,819)
(1,398,084)

Net current assets
  
 
 
1,963,971
 
 
1,893,299

Total assets less current liabilities
  
16,662,000
17,364,626

Creditors: amounts falling due after more than one year
 15 
(9,634,542)
(10,102,042)

Provisions for liabilities
  

Deferred tax
 17 
(951,803)
(593,277)

Other provisions
 18 
(191,567)
(149,497)

  
 
 
(1,143,370)
 
 
(742,774)

Net assets
  
5,884,088
6,519,810


Capital and reserves
  

Called up share capital 
 20 
855,450
855,450

Profit and loss account
 21 
5,028,638
5,664,360

  
5,884,088
6,519,810


Page 7

 
BIOGAS TECHNOLOGY LIMITED
REGISTERED NUMBER: 02323287
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 November 2025.




P Noland
Director

The notes on pages 10 to 23 form part of these financial statements.

Page 8

 
BIOGAS TECHNOLOGY LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025


Called up share capital
Profit and loss account
Total equity

£
£
£


At 1 April 2023
855,450
6,328,634
7,184,084


Comprehensive income for the year

Loss for the year
-
(664,274)
(664,274)
Total comprehensive income for the year
-
(664,274)
(664,274)


Total transactions with owners
-
-
-



At 1 April 2024
855,450
5,664,360
6,519,810


Comprehensive income for the year

Loss for the year
-
(635,722)
(635,722)
Total comprehensive income for the year
-
(635,722)
(635,722)


Total transactions with owners
-
-
-


At 31 March 2025
855,450
5,028,638
5,884,088


The notes on pages 10 to 23 form part of these financial statements.

Page 9

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Biogas Technology Limited is a private company limited by shares and incorporated in England and
Wales. The registered office is Edison House, Daniel Adamson Road, Salford, Manchester, M50 1DT.
Its principal activities are the provision of environmental services, including the design, manufacture,
implementation and sale of engineering solutions on landfill gas sites, together with the development,
construction and operation of electricity generation and storage facilities in the UK.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A;
the requirements of Section 26 Share-based Payment paragraphs 26.18(b), 26.19 to 26.21 and 26.23.

This information is included in the consolidated financial statements of Ylem Group Limited as at 31 March 2025 and these financial statements may be obtained from Companies House.

 
2.3

Going concern

The Company is a subsidiary of Ylem Group Limited. The parent company has confirmed its intention to support the Company for a period of at least twelve months from the date of signing these financial statements, to the extent required, and, having made enquiries of the parent company directors, the Company directors have no reason to doubt the parent’s ability to do so. 
The directors consider that the Company has adequate resources to continue in operation for the
foreseeable future, and so they continue to adopt the going concern basis in preparing the Annual
Financial Statements for the year ended 31 March 2025.

Page 10

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.4

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.5

Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. 
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably. 

 
2.6

Operating leases: the company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.7

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.8

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.9

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 11

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.10

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.11

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Assets under construction
-
Not Depreciated
Plant and machinery
-
5 years
Motor vehicles
-
3-4 years
Site assets
-
20 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 12

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.12

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.13

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.14

Cash

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. 

 
2.15

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.16

Provisions for liabilities

Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance Sheet.


Page 13

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.17

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.
Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Page 14

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

3.


Judgements in applying accounting policies and key sources of estimation uncertainty

In the application of the Company's accounting policies, which are described above, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
Key sources of estimation uncertainty
The Company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results.
Obsolete stock provision
Company management perform a detailed analysis of stock at the year end, to identify slow moving stocks and consider whether obsolescence provisions are needed.
Debtors
Debtors are reviewed in detail for any possible bad debt. Any bad debt identified is then provided for accordingly.
Accrued income
Accrued income is reviewed for any potentially loss-making contracts, and suitable provision made.


4.


Turnover

The Company's turnover relates to its principal activities, all of which are undertaken in the United
Kingdom.


5.


Operating profit

The operating profit is stated after charging:

2025
2024
£
£

Depreciation
827,397
900,946

Exchange Losses
-
5

Other operating lease rentals
99,264
145,995

Page 15

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

6.


Auditor's remuneration

2025
2024
£
£

Fees payable to the company's auditor for the audit of the company's financial statements
15,675
15,000

The company has taken advantage of the exemption not to disclose amounts paid for non-audit services as these are disclosed in the consolidated accounts of the parent company.


7.


Employees

The Company has no employees other than the directors, who did not receive any remuneration (2024 - £NIL).

The emoluments of the Directors are paid by a fellow group undertaking, which makes no recharge to the Company. They are Directors of a number of fellow subsidiaries and it is not possible to make an accurate apportionment to their emoluments in respect of each of the subsidaries.


8.


Interest payable and similar expenses

2025
2024
£
£


Bank loan interest payable
984,865
187,042

Group loan interest payable
-
1,657,001

984,865
1,844,043

Page 16

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

9.


Taxation


2025
2024
£
£



Group taxation relief prior period
76,854
(76,854)


Total current tax
76,854
(76,854)

Deferred tax


Origination and reversal of timing differences
186,230
(308,193)

Adjustments in respect of previous periods
172,296
119,722

Total deferred tax
358,526
(188,471)


Taxation on profit/(loss) on ordinary activities
435,380
(265,325)

Factors affecting tax charge for the year

The tax assessed for the year is higher than (2024 - higher than) the standard rate of corporation tax in the UK of 25% (2024 - 25%). The differences are explained below:

2025
2024
£
£


Loss on ordinary activities before tax
(200,342)
(929,599)


Loss on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 25%)
(50,086)
(232,400)

Effects of:


Fixed asset timing differences
2,009
10,052

Expenses not deductible for tax purposes
234,308
19,025

Income not taxable for tax purposes
-
(104,870)

Adjustments to tax charge in respect of prior periods
76,854
(76,854)

Adjustments to tax charge in respect of prior periods - deferred tax
172,295
119,722

Total tax charge for the year
435,380
(265,325)


Factors that may affect future tax charges

There were no factors that may affect future tax charges.

Page 17

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

10.


Tangible fixed assets





Site Assets
Plant and machinery
Motor vehicles
Assets under construction
Total

£
£
£
£
£



Cost or valuation


At 1 April 2024
16,360,950
170,307
1,895
156,350
16,689,502


Additions
226,481
-
-
(42,516)
183,965


Disposals
(122,382)
-
-
(7,484)
(129,866)


Exchange adjustments
(18,741)
-
-
-
(18,741)



At 31 March 2025

16,446,308
170,307
1,895
106,350
16,724,860



Depreciation


At 1 April 2024
1,050,771
165,509
1,895
-
1,218,175


Charge for the year
827,397
-
-
-
827,397


Exchange adjustments
(18,741)
-
-
-
(18,741)



At 31 March 2025

1,859,427
165,509
1,895
-
2,026,831



Net book value



At 31 March 2025
14,586,881
4,798
-
106,350
14,698,029



At 31 March 2024
15,310,179
4,798
-
156,350
15,471,327

Page 18

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

11.


Stocks

2025
2024
£
£

Stocks and work in progress
155,742
-

155,742
-



12.


Debtors

2025
2024
£
£


Trade debtors
54,007
76,943

Amounts owed by group undertakings
-
278,859

Other debtors
81,311
252,495

Prepayments and accrued income
887,325
531,044

1,022,643
1,139,341



13.


Cash

2025
2024
£
£

Cash at bank and in hand
2,323,405
2,152,042

2,323,405
2,152,042



14.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank loans
554,413
784,860

Trade creditors
168,725
216,202

Amounts owed to group undertakings
76,854
-

Accruals and deferred income
737,827
397,022

1,537,819
1,398,084


Amounts owed to group undertakings includes £76,854 (2024: £Nil) for group relief claimed.

Page 19

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

15.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loans
9,634,542
10,102,042

9,634,542
10,102,042


Amounts owed to bank are secured and repayable in not less than 12 months. Interest is charged at base rate plus 4% per annum.


16.


Loans


Analysis of the maturity of loans is given below:


2025
2024
£
£

Amounts falling due within one year

Bank loans
554,413
784,860


554,413
784,860

Amounts falling due 1-2 years

Bank loans
490,000
495,000


490,000
495,000

Amounts falling due 2-5 years

Bank loans
9,144,542
9,607,042


9,144,542
9,607,042


10,188,955
10,886,902


Close Leasing Limited hold a fixed and floating charge over the assets of the Company as security for the loan provided.

Page 20

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

17.


Deferred taxation




2025
2024


£

£






At beginning of year
(593,277)
(781,748)


Origination and reversal of timing differences
(186,230)
308,193


Adjustments in respect of prior periods
(172,296)
(119,722)



At end of year
(951,803)
(593,277)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
(3,462,907)
(3,676,983)

Losses and other deductions
2,511,104
3,083,706

(951,803)
(593,277)


18.


Provisions




Closure costs provision

£





At 1 April 2024
149,497


Provided in year
42,070



At 31 March 2025
191,567

The Company has a contractual obligation to complete certain works to restore a site once the project
has finished and the site has been vacated.

Page 21

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

19.


Commitments under operating leases

At 31 March 2025 the company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2025
2024
£
£


Not later than 1 year
101,322
86,000

Later than 1 year and not later than 5 years
405,289
344,000

Later than 5 years
1,177,621
1,087,559

1,684,232
1,517,559


20.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



855,450 (2024 - 855,450) Ordinary Shares of £1 each
855,450
855,450


There is a single class of ordinary shares. There are no restrictions on dividends and the repayment of
capital.


21.


Reserves

Profit and loss account

Includes all current and prior period retained profits and losses.


22.


Related party transactions

The Company has claimed the exemption contained in section 33 of FRS 102, which is available to wholly-owned subsidiaries, not to disclose related party transactions with other members of the Group.

Page 22

 
BIOGAS TECHNOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

23.


Controlling party

During the year ended 31 March 2025, the immediate and ultimate holding company was Ylem Group Limited; a company incorporated in the United Kingdom, whose registered address is the same as the Company's as disclosed on the Company Information page. Ylem Group Limited was the parent of the largest and smallest group of companies, of which the Company is a member, that produces consolidated accounts. Ylem Group Limited was ultimately owned by a family trust of Mr Tim Scott, which was considered to be the ultimate controlling party.
On 18th November 2025, Atari Limited, a Company registered in Jersey became the immediate and ultimate parent undertaking of Ylem Group Limited. Atari Limited is owned by a family trust of Mr Tim Scott, which is considered to be the ultimate controlling party.
Group financial statements for Ylem Group Limited are available from Companies House, Crown Way, Cardiff, CF14 3UZ.

Page 23